Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06520865 · ClinicalTrials.gov registry record
TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis
A clinical trial of Tinnitus, sponsored by University of Regensburg.
- Completed
- Registry status
- 560
- Enrollment target
- 7
- Study locations
NCT06520865: Completed study of Tinnitus, sponsored by University of Regensburg.
NCT06520865 is a study of Tinnitus that has completed, run by University of Regensburg. The registered enrollment target is 560 participants, below the 12,596-participant average among 24 other Tinnitus trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06520865, a study of Tinnitus, has completed, sponsored by University of Regensburg.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
- 7
- Study locations
Study Summary
Research in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinnitus, the clinical management of tinnitus remains largely based on a 'trial and error' approach. The identification and validation of a biomarker for tinnitus is thought to be the crucial step in the development of a personalized approach to the diagnosis and treatment of tinnitus. The overarching goal of this study is to incorporate advanced technologies to provide an objective, data-driven, personalized approach to the diagnosis of chronic tinnitus. This should lead to a clinically applicable tool that can be widely and easily used.
Primary Outcome
Event-related potentials of a 64-channel EEG
Conditions Studied
Interventions
- OTHER Acoustic paradigms
Study Locations (7)
Other
- Brai3n - Research center for Advanced, International, Innovative and Interdisciplinary Neuromodulation - Ghent
- Trinity College Dublin - Dublin
- OST - Eastern Switzerland University of Applied Sciences - Sankt Gallen
Illinois
- University of Illinois - Champaign
Texas
- University of Texas - Austin
Baden-Wurttemberg
- University of Tuebingen - Tübingen
Bavaria
- Center of Neuromodulation - Psychiatry und Psychotherapie der Universität Regensburg am Bezirksklinikum - Regensburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-11-30 |
What the finished NCT06520865 record still lists
NCT06520865 is an observational study that tracks outcomes without assigning an intervention. The registered 560 participants enrollment target is mid-sized for trials with a published cap, below the 12,596-participant average among 24 other Tinnitus trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Acoustic paradigms is the first listed.
NCT06520865 lists 7 locations in 5 states (Other, Illinois, Texas).
Frequently Asked Questions
What is clinical trial NCT06520865 about?
NCT06520865 is a clinical study titled "TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis". Research in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinnitus, the clinical ma...
What is the current status of trial NCT06520865?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2024-08-01. Estimated completion is 2025-11-30.
What conditions does trial NCT06520865 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT06520865?
The interventions under investigation include: Acoustic paradigms (OTHER).
Who is sponsoring clinical trial NCT06520865?
This trial is sponsored by University of Regensburg, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06520865 being conducted?
This trial has 7 study locations across Illinois, Texas, Baden-Wurttemberg, Bavaria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06520865's enrollment target sits among peer trials
560 2nd of 24 the highest of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
RECRUITING · Early Phase 1
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
-
External Therapy for Tinnitus Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI